Huadong Pharmaceutical: Supervisory Board\'s Verification Opinions on the Company\'s 2022 Restricted Stock Incentive Plan reserves and grants restricted shares for the first time during the sales restriction period to lift the sales restriction conditions

SZSI · Oct 11

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

华东医药：监事会关于公司2022年限制性股票激励计划预留授予限制性股票第一个解除限售期解除限售条件成就的核查意见

Huadong Pharmaceutical: Supervisory Board\'s Verification Opinions on the Company\'s 2022 Restricted Stock Incentive Plan reserves and grants restricted shares for the first time during the sales restriction period to lift the sales restriction conditions

Risk Disclaimer

Statement